[Form 4] DBV Technologies S.A. Insider Trading Activity

Rhea-AI Filing Summary

DBV Technologies S.A. (DBVT) reported a Form 4 insider transaction for its Chief Executive Officer and director. On 11/21/2025, the reporting person received an employee stock option grant to buy 964,000 ordinary shares of DBV Technologies.

The option has an exercise price of $2.9 per share, stated in U.S. dollars and based on converting euros at an exchange rate of $1.15154 to €1.00 as of November 21, 2025. These options are exercisable until 11/21/2035 and were fully reported as directly owned.

The option vests in four equal annual installments starting on November 21, 2026, as long as the executive continues to provide service through each vesting date. This filing reflects an equity-based compensation award rather than an open-market purchase or sale of shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tasse Daniel

(Last) (First) (Middle)

C/O DBV TECHNOLOGIES S.A.

107, AVENUE DE LA REPUBLIQUE

(Street)

CHATILLON I0 92320

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$2.9(1)	11/21/2025		A		964,000		(2)	11/21/2035	Ordinary Shares	964,000	$0	964,000	D

Explanation of Responses:

1. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.

2. The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

	/s/ Virginie Boucinha, Attorney-in-Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DBV Technologies (DBVT) report in this Form 4?

DBV Technologies reported that its Chief Executive Officer and director received an employee stock option grant covering 964,000 ordinary shares on 11/21/2025.

What is the exercise price of the DBVT stock options granted on November 21, 2025?

The employee stock options have an exercise price of $2.9 per share, with the price stated in U.S. dollars after converting from euros.

How and when do the DBV Technologies (DBVT) options granted to the CEO vest?

The option will vest in four equal annual installments starting on November 21, 2026, subject to the CEO continuing to provide service on each vesting date.

What is the expiration date of the DBVT employee stock options reported?

The employee stock options reported in the Form 4 expire on 11/21/2035, giving a long-term window during which they may be exercised after vesting.

In what currency is the DBV Technologies option exercise price denominated?

The exercise price is denominated in U.S. dollars and reflects a conversion from euros using an exchange rate of $1.15154 to €1.00 as of November 21, 2025.

What role does the reporting person hold at DBV Technologies (DBVT)?

The reporting person is both a Director and an Officer, serving as the company’s Chief Executive Officer.